Thrombocytopenia in pregnancy, a common condition affecting mother and fetus, requires careful management. Advances in understanding immune-mediated platelet destruction and potential treatments like intravenous immunoglobulin (IVIg) offer hope, but further research is needed.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: